Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15921393rdf:typepubmed:Citationlld:pubmed
pubmed-article:15921393lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0393022lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0059985lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C1550587lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0234227lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C1518071lld:lifeskim
pubmed-article:15921393lifeskim:mentionsumls-concept:C0686907lld:lifeskim
pubmed-article:15921393pubmed:issue5lld:pubmed
pubmed-article:15921393pubmed:dateCreated2005-5-30lld:pubmed
pubmed-article:15921393pubmed:abstractTextWhether the addition of rituximab to fludarabine and cyclosphosphamide (FC) increases early or late infection risk remains poorly defined. This retrospective analysis of 160 patients treated with FC+/-rituximab found no evidence of increased infection among patients receiving FC+rituximab, providing some evidence of safety for the continued exploration of this regimen.lld:pubmed
pubmed-article:15921393pubmed:languageenglld:pubmed
pubmed-article:15921393pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:citationSubsetIMlld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15921393pubmed:statusMEDLINElld:pubmed
pubmed-article:15921393pubmed:monthMaylld:pubmed
pubmed-article:15921393pubmed:issn1592-8721lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:CampbellPhili...lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:SeymourJohn...lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:GriggAndrew...lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:BrownMichaelMlld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:UnderhillCrai...lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:RitchieDavidDlld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:TamConstantin...lld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:ScarlettJohnJlld:pubmed
pubmed-article:15921393pubmed:authorpubmed-author:BondRodneyRlld:pubmed
pubmed-article:15921393pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15921393pubmed:volume90lld:pubmed
pubmed-article:15921393pubmed:ownerNLMlld:pubmed
pubmed-article:15921393pubmed:authorsCompleteYlld:pubmed
pubmed-article:15921393pubmed:pagination700-2lld:pubmed
pubmed-article:15921393pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:meshHeadingpubmed-meshheading:15921393...lld:pubmed
pubmed-article:15921393pubmed:year2005lld:pubmed
pubmed-article:15921393pubmed:articleTitleEarly and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.lld:pubmed
pubmed-article:15921393pubmed:publicationTypeLetterlld:pubmed
pubmed-article:15921393pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15921393pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15921393lld:pubmed